Thus, these studies indicated that H3K9me3, as well as its methyltransferases SETDB1 and SUV39H1, play important regulatory roles in glioma development and progression and may represent novel targets for targeted therapy of glioma. Here, SUV39H1 is linked to central nervous system cancer.